Steelco and Belimed Joint Venture - FAQ
Frequently Asked Questions (FAQ)
What is changing in Australia and New Zealand?
Further to the SteelcoBelimed Joint Venture integration, In Vitro Technologies has been appointed as the exclusive distributor for Steelco and Belimed equipment across Australia and New Zealand effective 1 January 2027.
Will my current products or services change?
No immediate changes are planned regarding current customer support and ongoing projects. Activities during the transition period will continue in accordance with existing contractual obligations and agreed transition arrangements. Any future updates relating to sales, service or support arrangements will be communicated in advance.
Will there be any interruption to service?
There will be no disruption to normal operations. Orders, deliveries and support activities will continue throughout the transition period in accordance with existing agreements and contractual obligations.
Will my existing orders still be fulfilled?
Yes. All confirmed orders and ongoing projects will continue to be processed, delivered and supported as planned.
After 1 January 2027, who should I contact if I wish to purchase new Steelco or Belimed equipment?
From 1 January 2027, In Vitro Technologies will become the official and exclusive distributor for new Steelco and Belimed equipment sales in Australia and New Zealand.
Existing projects, tenders and agreements awarded or formally submitted prior to 31 December 2026 will continue to be managed under existing arrangements.
What will happen to existing service agreements currently managed under previous arrangements?
Existing service agreements that remain valid beyond 31 December 2026 will continue to be supported under the current arrangements for the duration of the agreement. For customers without an active service agreement, In Vitro Technologies will become the primary contact point for service and support from 1 January 2027. Customers seeking future service and support information will be able to contact In Vitro Technologies directly for assistance and guidance.
What support structure will In Vitro Technologies provide moving forward?
In Vitro Technologies will provide local sales, project coordination, installation, technical service, customer support, education and after-sales support for the Steelco and Belimed portfolio across Australia and New Zealand.
Which application areas will In Vitro Technologies support within the Steelco and Belimed portfolio?
In Vitro Technologies will support Healthcare, Laboratories and Bio Medical Research (BMR) applications across Australia and New Zealand in accordance with the agreed distribution scope.
Who do I contact for support during the transition?
Customers will continue to receive regular updates regarding sales, technical service and customer support throughout the transition period. Please contact your local account manager or customer support representative for assistance.